{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:14:38Z","timestamp":1787764478177,"version":"build-2784847793"},"reference-count":309,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016126","name":"Beijing Hospital Authority","doi-asserted-by":"publisher","award":["DFL20220301"],"award-info":[{"award-number":["DFL20220301"]}],"id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20230484445"],"award-info":[{"award-number":["20230484445"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.apjo.2025.100261","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:51:06Z","timestamp":1762573866000},"page":"100261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["International consensuses and guidelines on managing ocular Beh\u00e7et\u2019s disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-Retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII) and the Academia Retina Internationalis (ARI)"],"prefix":"10.1016","volume":"14","author":[{"given":"Victor T.T.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-7035","authenticated-orcid":false,"given":"Andrew C.Y.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmay","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1443-3726","authenticated-orcid":false,"given":"Carmen K.M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Phaik","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cordero-Coma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6566-1019","authenticated-orcid":false,"given":"Danny S.C.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle A.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pavesio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhum","family":"Silpa-Archa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-5493","authenticated-orcid":false,"given":"Justine R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenru","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4020-453X","authenticated-orcid":false,"given":"Ilknur","family":"Tugal-Tutkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2647-6619","authenticated-orcid":false,"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/RHU.0000000000000424","article-title":"Rheumatologists and ophthalmologists differ in treatment decisions for Ocular behcet disease","volume":"22","author":"Palestine","year":"2016","journal-title":"J Clin Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2025.100144","article-title":"Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS)","volume":"14","author":"Ruamviboonsuk","year":"2025","journal-title":"Asia Pac J Ophthalmol"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12016-013-8355-1","article-title":"Clinical guidelines and definitions of autoinflammatory diseases: contrasts and comparisons with autoimmunity-a comprehensive review","volume":"45","author":"Zen","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/07853890.2011.598546","article-title":"Clinical and biochemical landmarks in systemic autoinflammatory diseases","volume":"44","author":"Cantarini","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/j.apjo.2025.100261_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00003086-197909000-00003","article-title":"A unifying concept for the spondyloarthropathies","volume":"143","author":"Wright","year":"1979","journal-title":"Clin Orthop Relat Res"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568010053622894","article-title":"Behcet's disease as an autoinflammatory disorder","volume":"4","author":"Gul","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib8","first-page":"291","article-title":"Behcet's Disease: Autoimmune or Autoinflammatory?","volume":"8","author":"Hedayatfar","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"MHC-I-opathy'-unified concept for spondyloarthritis and Behcet disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheuma"},{"key":"10.1016\/j.apjo.2025.100261_bib10","article-title":"Innate and Adaptive Responses to Heat Shock Proteins in Behcet's Disease","volume":"2013","author":"Direskeneli","year":"2013","journal-title":"Genet Res Int"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","article-title":"Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?","volume":"45","author":"Direskeneli","year":"2006","journal-title":"Rheumatol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08830189709116840","article-title":"The place of Behcet's syndrome among the autoimmune diseases","volume":"14","author":"Yazici","year":"1997","journal-title":"Int Rev Immunol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine"},{"issue":"sup1","key":"10.1016\/j.apjo.2025.100261_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00325481.2022.2159205","article-title":"Behcet disease: an undifferentiating and complex vasculitis","volume":"135","author":"Pak","year":"2023","journal-title":"Post Med"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jvsv.2018.11.006","article-title":"Increased vein wall thickness in Behcet disease","volume":"7","author":"Seyahi","year":"2019","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11739-019-02046-y","article-title":"Phenotypes in Behcet's syndrome","volume":"14","author":"Seyahi","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","article-title":"Pathogenesis of Behcet's disease: autoinflammatory features and beyond","volume":"37","author":"Gul","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Behcet's disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib20","first-page":"345","article-title":"Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behcet's disease: correlations with disease activity and severity","volume":"31","author":"Yosipovitch","year":"1995","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.apjo.2025.100261_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.713052","article-title":"Pathogenesis of Behcet's Syndrome: Genetic, Environmental and Immunological Factors","volume":"8","author":"Mattioli","year":"2021","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.60.11.1074","article-title":"Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study","volume":"60","author":"Diri","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib23","first-page":"2393","article-title":"Target organ associations in Turkish patients with Behcet's disease: a cross sectional study by exploratory factor analysis","volume":"29","author":"Tunc","year":"2002","journal-title":"J Rheuma"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.23450","article-title":"Increased enthesopathy among Behcet's syndrome patients with acne and arthritis: an ultrasonography study","volume":"58","author":"Hatemi","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","article-title":"Behcet syndrome: is it one condition?","volume":"43","author":"Yazici","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.apjo.2025.100261_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-7-20","article-title":"Behcet's disease","volume":"7","author":"Saadoun","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1523-1747.2002.01798.x","article-title":"A historical review of early descriptions of Adamantiades-Behcet's disease","volume":"119","author":"Zouboulis","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/rheumatology\/38.12.1171","article-title":"Behcet's syndrome","volume":"38","author":"Barnes","year":"1999","journal-title":"Rheumatol"},{"key":"10.1016\/j.apjo.2025.100261_bib29","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease. Lancet. May 5 1990;335(8697):1078-1080May 5 1990.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"10.1016\/j.apjo.2025.100261_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/607921","article-title":"Diagnosis\/Classification Criteria for Behcet's Disease","volume":"2012","author":"Davatchi","year":"2012","journal-title":"Pathol Res Int"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00403-009-1008-9","article-title":"The skin pathergy test: innately useful?","volume":"302","author":"Varol","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.apjo.2025.100261_bib32","doi-asserted-by":"crossref","unstructured":"International Team for the Revision of the International Criteria for Behcet's D. The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. Mar 2014;28(3):338-347. doi:10.1111\/jdv.12107Mar 2014.","DOI":"10.1111\/jdv.12107"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib33","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1093\/rheumatology\/keac018","article-title":"Evaluation of sensitivity and specificity of diagnostic criteria for Behcet's disease in the absence of a gold standard","volume":"61","author":"Zhong","year":"2022","journal-title":"Rheumatolgy"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib34","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of Neuro-Behcet's disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib35","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","article-title":"Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: PEDBD","volume":"75","author":"Kone-Paut","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib36","first-page":"119","article-title":"The performance of different classification criteria in paediatric Behcet's disease","volume":"35 108","author":"Batu","year":"2017","journal-title":"Clin Exp Rheuma"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Behcet syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat Rev Rheuma"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/31.11.767","article-title":"Clinical differentiation of oral ulceration in Behcet's disease","volume":"31","author":"Main","year":"1992","journal-title":"Br J Rheuma"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-4362.1998.00401.x","article-title":"A randomized, controlled and blinded study of papulopustular lesions in Turkish Behcet's patients","volume":"37","author":"Alpsoy","year":"1998","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib40","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/ard.2003.017467","article-title":"The pustular skin lesions in Behcet's syndrome are not sterile","volume":"63","author":"Hatemi","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"6 94","key":"10.1016\/j.apjo.2025.100261_bib41","first-page":"S101","article-title":"Histopathological and clinical evaluation of papulopustular lesions in Behcet's disease","volume":"33","author":"Kutlubay","year":"2015","journal-title":"Clin Exp Rheuma"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib42","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0190-9622(95)91333-5","article-title":"Mucocutaneous criteria for the diagnosis of Behcet's disease: an analysis of clinicopathologic data from multiple international centers","volume":"32","author":"Jorizzo","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13010041","article-title":"Update on the Diagnosis of Behcet's Disease","volume":"13","author":"Alibaz-Oner","year":"2022","journal-title":"Diagnostics"},{"issue":"7842","key":"10.1016\/j.apjo.2025.100261_bib44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(73)93343-6","article-title":"Letter: HL-A5 and Behcet's disease","volume":"2","author":"Ohno","year":"1973","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/09273948.2011.634978","article-title":"HLA-B*51 and Behcet Disease","volume":"20","author":"Gul","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMra2305712","article-title":"Behcet's Syndrome","volume":"390","author":"Saadoun","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib47","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib48","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/08830185.2020.1851372","article-title":"A comprehensive overview on the genetics of Behcet's disease","volume":"41","author":"Mahmoudi","year":"2022","journal-title":"Int Rev Immunol"},{"issue":"5 24","key":"10.1016\/j.apjo.2025.100261_bib50","first-page":"S6","article-title":"Behcet's disease: an update on the pathogenesis","volume":"19","author":"Gul","year":"2001","journal-title":"Clin Exp Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib51","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1038\/s41598-019-40824-y","article-title":"The association analysis between HLA-A*26 and Behcet's disease","volume":"9","author":"Nakamura","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1399-0039.1997.tb02835.x","article-title":"A strong association between HLA-B*5101 and Behcet's disease in Greek patients","volume":"50","author":"Mizuki","year":"1997","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2009.108571","article-title":"Genetics of Behcet disease inside and outside the MHC","volume":"69","author":"Meguro","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4 60","key":"10.1016\/j.apjo.2025.100261_bib54","first-page":"S39","article-title":"Genetic association of HLA-A*2601 with ocular Behcet's disease in Japanese patients","volume":"28","author":"Kaburaki","year":"2010","journal-title":"Clin Exp Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/14397595.2019.1705538","article-title":"HLA-A26 is a risk factor for Behcet's disease ocular lesions","volume":"31","author":"Kato","year":"2021","journal-title":"Mod Rheuma"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3346\/jkms.2003.18.2.231","article-title":"Influence of sex on patients with Behcet's disease in Korea","volume":"18","author":"Bang","year":"2003","journal-title":"J Korean Med Sci"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib57","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1002\/art.24149","article-title":"Population-based prevalence study of Behcet's disease: differences by ethnic origin and low variation by age at immigration","volume":"58","author":"Mahr","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib58","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3346\/jkms.2001.16.5.615","article-title":"Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter study","volume":"16","author":"Bang","year":"2001","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib59","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1479-8077.2006.00208.x","article-title":"Clinical manifestations of Behcet's disease in Chinese patients","volume":"9","author":"Zhang","year":"2006","journal-title":"APLAR J Rheumatol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1610-0387.2006.05841.x","article-title":"Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany -- current pathogenetic concepts and therapeutic possibilities","volume":"4","author":"Altenburg","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib61","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10067-010-1430-6","article-title":"Behcet's disease: from East to West","volume":"29","author":"Davatchi","year":"2010","journal-title":"Clin Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/rheumatology\/kew486","article-title":"Exploring the variability in Behcet's disease prevalence: a meta-analytical approach","volume":"57","author":"Maldini","year":"2018","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.20452\/pamw.4233","article-title":"Considerations in designing and interpreting prevalence studies for Behcet syndrome","volume":"128","author":"Hatemi","year":"2018","journal-title":"Pol Arch Intern Med"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009740600991927","article-title":"Systematic review of ethnic variation in the phenotype of Behcet's disease","volume":"36","author":"Lewis","year":"2007","journal-title":"Scand J Rheuma"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib65","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2340\/0001555562158159","article-title":"The validity of the pathergy test (non-specific skin hyperreactivity) in Behcet's disease: a double-blind study by independent observers","volume":"62","author":"Altac","year":"1982","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib66","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Behcet's disease in Istanbul, Turkey","volume":"42","author":"Azizlerli G","year":"2003","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10384-005-0261-5","article-title":"Statistical analysis of endogenous uveitis at Tokyo University Hospital (1998-2000)","volume":"50","author":"Akiyama","year":"2006","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.22500","article-title":"Epidemiology and clinical course of Behcet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study","volume":"57","author":"Salvarani","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib69","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.24423","article-title":"Epidemiology and clinical characteristics of Behcet's disease in the US: a population-based study","volume":"61","author":"Calamia","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/RHU.0000000000001996","article-title":"Characteristics of Patients With Behcet Disease From the Van Province, Eastern Turkey: Definition of Disease Clusters in a Tertiary Referral Center","volume":"29","author":"Oguz","year":"2023","journal-title":"J Clin Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0000000000000125","article-title":"An update on the diagnosis, treatment, and prognosis of intestinal Behcet's disease","volume":"27","author":"Cheon","year":"2015","journal-title":"Curr Opin Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.rdc.2017.09.007","article-title":"Gastrointestinal Involvement in Behcet Disease","volume":"44","author":"Hatemi","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.apjo.2025.100261_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/0-306-48382-3_14","article-title":"Clinical manifestations and course of 200 Japanese patients with Behcet's disease","volume":"528","author":"Tanaka","year":"2003","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib74","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ard.55.3.208","article-title":"Gastrointestinal involvement in Behcet's syndrome: a controlled study","volume":"55","author":"Yurdakul","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"10.1016\/j.apjo.2025.100261_bib75","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003348","article-title":"Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet's Syndrome: A Strobe-Compliant Observational Study From a Dedicated Multidisciplinary Center","volume":"95","author":"Hatemi","year":"2016","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib76","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/RHU.0b013e31823a46ed","article-title":"Behcet disease: clinical features and management in a Brazilian tertiary hospital","volume":"17","author":"Oliveira","year":"2011","journal-title":"J Clin Rheuma"},{"issue":"4 84","key":"10.1016\/j.apjo.2025.100261_bib77","first-page":"S33","article-title":"Registry of the Spanish network of Behcet's disease: a descriptive analysis of 496 patients","volume":"32","author":"Rodriguez-Carballeira","year":"2014","journal-title":"Clin Exp Rheuma"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib78","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1331.2006.01613.x","article-title":"Neuro-Behcet's disease in Caucasians: a study of 22 patients","volume":"14","author":"Joseph","year":"2007","journal-title":"Eur J Neurol"},{"issue":"4 67","key":"10.1016\/j.apjo.2025.100261_bib79","first-page":"S47","article-title":"Characteristics of vascular involvement in Behcet's disease in Japan: a retrospective cohort study","volume":"29","author":"Ideguchi","year":"2011","journal-title":"Clin Exp Rheuma"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib80","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/rheumatology\/40.6.652","article-title":"AM. Thrombosis in Behcet's disease: a retrospective survey from a single UK centre","volume":"40","author":"Steuer","year":"2001","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib81","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bjo.2007.123554","article-title":"Ocular features of Behcet's disease: an international collaborative study","volume":"91","author":"Kitaichi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100261_bib82","doi-asserted-by":"crossref","unstructured":"Classification Criteria for Beh\u00e7et Disease Uveitis. Am J Ophthalmol. Aug 2021;228:80-88. doi:10.1016\/j.ajo.2021.03.058Aug 2021.","DOI":"10.1016\/j.ajo.2021.03.058"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Behcet disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib84","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ophtha.2007.04.056","article-title":"Clinical features of chinese patients with Beh\u00e7et's disease","volume":"115","author":"Yang","year":"2008","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09273948.2011.649153","article-title":"Controversies in Beh\u00e7et disease","volume":"20","author":"Wakefield","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib86","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10792-008-9203-9","article-title":"Pattern of uveitis in Beh\u00e7et's disease in a referral center in Tunisia, North Africa","volume":"29","author":"Khairallah","year":"2009","journal-title":"Int Ophthalmol"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib87","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/09273948.2013.795228","article-title":"Differential diagnosis of Beh\u00e7et uveitis","volume":"21","author":"Tugal-Tutkun","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0974-9233.58425","article-title":"Behcet's Uveitis","volume":"16","author":"Tugal-Tutkun","year":"2009","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.preteyeres.2007.09.002","article-title":"Beh\u00e7et's disease: ocular effects and treatment","volume":"27","author":"Deuter","year":"2008","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib90","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-005-0307-8","article-title":"Neovascularization of the optic disc in Beh\u00e7et's disease","volume":"50","author":"Tugal-Tutkun","year":"2006","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/09273948.2010.513798","article-title":"Beh\u00e7et disease presenting with frosted branch angiitis","volume":"19","author":"Jackson","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib92","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3341\/kjo.2013.27.6.466","article-title":"Frosted branch angiitis as ocular manifestation of Beh\u00e7et's disease: unusual case report and literature review","volume":"27","author":"Kwon","year":"2013","journal-title":"Korean J Ophthalmol"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib93","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jfo.2021.03.002","article-title":"Frosted branch angiitis in Beh\u00e7et's disease","volume":"44","author":"Bajjouk","year":"2021","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2014.10.013","article-title":"Uveitis in Behcet disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group","volume":"159","author":"Arevalo","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib95","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/112067210201200514","article-title":"Posterior segment involvement in ocular Behcet's disease","volume":"12","author":"Ozdal","year":"2002","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib96","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajo.2011.05.032","article-title":"Behcet disease: visual prognosis and factors influencing the development of visual loss","volume":"152","author":"Taylor","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib97","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/aos.15645","article-title":"Retinal vascular occlusions in ocular Behcet disease - a comparative analysis","volume":"101","author":"Ostrovsky","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/09273948.2011.630550","article-title":"Behcet uveitis in the American midwest","volume":"20","author":"Saleh","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09273948.2016.1205100","article-title":"Review for Diagnostics of the Year: Multimodal Imaging in Beh\u00e7et Uveitis","volume":"25","author":"Tugal-Tutkun","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.apjo.2025.100261_bib100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/APO.0000000000000584","article-title":"Recent Advances in Clinical Applications of Imaging in Retinal Diseases","volume":"12","author":"Szeto","year":"2023","journal-title":"Asia Pac J Ophthalmol"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib101","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/IAE.0000000000000197","article-title":"Use of ultra-wide-field retinal imaging in the management of active Behcet retinal vasculitis","volume":"34","author":"Mesquida","year":"2014","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12348-012-0075-9","article-title":"Macular involvement in patients with Behcet's uveitis","volume":"2","author":"Kahloun","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib103","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/s41433-020-01294-z","article-title":"Preclinical ocular features in patients with Behcet's disease detected by optical coherence tomography angiography","volume":"35","author":"Karalezli","year":"2021","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib104","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s10792-018-1059-z","article-title":"Quantitative analysis of retinal microcirculation in optical coherence tomography angiography in cases with Behcet's disease without ocular involvement","volume":"39","author":"Comez","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0323192","article-title":"OCTA measurements in Behcet's disease across different stages of the disease activity: A systematic review and meta-analysis","volume":"20","author":"Mozafar","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.apjo.2025.100261_bib106","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/APO.0000000000000594","article-title":"The Large Hellenic Study of Uveitis: Diagnostic and Therapeutic Algorithms, Complications, and Final Outcome","volume":"12","author":"Kalogeropoulos","year":"2023","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100261_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2024.100085","article-title":"Understanding natural language: Potential application of large language models to ophthalmology","volume":"13","author":"Yang","year":"2024","journal-title":"Asia Pac J Ophthalmol"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib108","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.22583","article-title":"Distinctions between diagnostic and classification criteria?","volume":"67","author":"Aggarwal","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib109","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/09273948.2020.1736310","article-title":"An Algorithm for the Diagnosis of Beh\u00e7et Disease Uveitis in Adults","volume":"29","author":"Tugal-Tutkun","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","article-title":"Beh\u00e7et's disease: evaluation of a new instrument to measure clinical activity","volume":"38","author":"Bhakta","year":"1999","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib111","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3904\/kjim.2016.31.1.170","article-title":"Validation and reliability of a Behcet's syndrome activity scale in Korea","volume":"31","author":"Choi","year":"2016","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.apjo.2025.100261_bib112","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10384-013-0294-0","article-title":"Behcet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab","volume":"58","author":"Kaburaki","year":"2014","journal-title":"Jpn J Ophthalmol"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib113","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/bjophthalmol-2015-307362","article-title":"Behcet's disease ocular attack score 24 and visual outcome in patients with Behcet's disease","volume":"100","author":"Tanaka","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib114","first-page":"931","article-title":"Development of the BD-QoL: a quality of life measure specific to Beh\u00e7et's disease","volume":"31","author":"Gilworth","year":"2004","journal-title":"J Rheuma"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib116","first-page":"1560","article-title":"Assessing quality of life in Beh\u00e7et's disease: a systematic review","volume":"40","author":"Mastrolia","year":"2022","journal-title":"Clin Exp Rheuma"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib117","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajo.2008.06.019","article-title":"Ocular inflammation in Beh\u00e7et disease: incidence of ocular complications and of loss of visual acuity","volume":"146","author":"Ka\u00e7maz","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib118","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/09273948.2015.1094095","article-title":"Ocular Beh\u00e7et's disease: changing patterns over time, complications and long-term visual prognosis","volume":"25","author":"Accorinti","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib119","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1726-4901(08)70159-X","article-title":"Behcet's disease with uveitis in Taiwan","volume":"71","author":"Chung","year":"2008","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib120","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000146080","article-title":"Visual prognosis and risk factors for korean patients with behcet uveitis","volume":"222","author":"Cho","year":"2008","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib121","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2017.1351570","article-title":"Ocular Manifestations and Visual Outcomes of Beh\u00e7et's Uveitis in a Thai population","volume":"27","author":"Pathanapitoon","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib122","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/08820538.2020.1772318","article-title":"A Clinical Audit on the Predictors for Visual Morbidity in Patients with Beh\u00e7et's Disease Attending Cairo University Hospitals","volume":"35","author":"Allam","year":"2020","journal-title":"Semin Ophthalmol"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib123","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00417-005-0005-8","article-title":"Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement","volume":"243","author":"Takeuchi","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib124","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1080\/09273948.2023.2288905","article-title":"Treatment Adherence Effect on the Visual Acuity of Beh\u00e7et's Uveitis Patients","volume":"32","author":"Oklar","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Behcet's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4274\/tjo.galenos.2019.60308","article-title":"Behcet's Uveitis: Current Diagnostic and Therapeutic Approach","volume":"50","author":"Cakar Ozdal","year":"2020","journal-title":"Turk J Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib127","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/09273948.2013.866257","article-title":"Therapy of ocular Behcet disease","volume":"22","author":"Zierhut","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"issue":"8647","key":"10.1016\/j.apjo.2025.100261_bib128","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Behcet's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial","volume":"76","author":"Ozyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Behcet's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.apjo.2025.100261_bib132","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713689008999414","article-title":"Cyclosporin A treatment of Behcet's disease: a long-term study","volume":"9","author":"Diaz-Llopis","year":"1990","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib133","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","article-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease","volume":"118","author":"Whitcup","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib134","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/acr.20308","article-title":"Azathioprine in severe uveitis of Behcet's disease","volume":"62","author":"Saadoun","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1021227019915","article-title":"Long-term therapy with low dose cyclosporin A in ocular Behcet's disease","volume":"105","author":"Ozdal","year":"2002","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100261_bib136","first-page":"S84","article-title":"Cyclosporine for Behcet's uveitis: is it associated with an increased risk of neurological involvement?","volume":"26","author":"Akman-Demir","year":"2008","journal-title":"Clin Exp Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib137","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12886-018-0929-5","article-title":"Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents","volume":"18","author":"Celiker","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib138","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/BOR.0000000000000911","article-title":"Uveitis in Behcet disease - an update","volume":"35","author":"Tugal-Tutkun","year":"2023","journal-title":"Curr Opin Rheuma"},{"key":"10.1016\/j.apjo.2025.100261_bib139","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3389\/fphar.2020.00941","article-title":"Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets' Disease-Associated Uveitis: A Systematic Review and Meta-Analysis","volume":"11","author":"Hu","year":"2020","journal-title":"Front Pharm"},{"key":"10.1016\/j.apjo.2025.100261_bib140","article-title":"Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behcet's disease: A systematic review of controlled trials","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharm"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib141","doi-asserted-by":"crossref","first-page":"813","DOI":"10.18240\/ijo.2022.05.19","article-title":"Effects of anti-TNF biologic drugs on uveitis severity in Behcet patients: systematic review and Meta-analysis","volume":"15","author":"Abolhasani","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib142","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib143","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100261_bib144","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14728214.2020.1847271","article-title":"Behcet's disease uveitis: is there a need for new emerging drugs?","volume":"25","author":"Tugal-Tutkun","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib146","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/rheumatology\/keu266","article-title":"Anti-TNF-alpha therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients","volume":"53","author":"Calvo-Rio","year":"2014","journal-title":"Rheumatology"},{"issue":"9278","key":"10.1016\/j.apjo.2025.100261_bib147","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Behcet's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib148","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/rheumatology\/keq366","article-title":"A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behcet's disease: a comparative 4-week study","volume":"50","author":"Markomichelakis","year":"2011","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib149","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5152\/eurjrheum.2017.16112","article-title":"Rapid loss of efficacy of biosimilar infliximab in three patients with Behcet's disease after switching from infliximab originator","volume":"4","author":"Cantini","year":"2017","journal-title":"Eur J Rheuma"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib150","first-page":"111","article-title":"Biosimilar infliximab for Behcet's syndrome: a case series","volume":"37 121","author":"Dincses","year":"2019","journal-title":"Clin Exp Rheuma"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib151","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bjo.2009.174888","article-title":"Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease","volume":"95","author":"Sugita","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib152","first-page":"9","article-title":"Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behcet's disease","volume":"5","author":"Ueda","year":"2018","journal-title":"Eur J Rheuma"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib153","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease: an open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib154","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in Patients with Active Noninfectious Uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"issue":"10050","key":"10.1016\/j.apjo.2025.100261_bib155","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib156","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1016\/S2665-9913(24)00194-2","article-title":"Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behcet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial","volume":"6","author":"Zhong","year":"2024","journal-title":"Lancet Rheuma"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib157","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/art.41026","article-title":"Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behcet's Disease: National Multicenter Study of 177 Cases","volume":"71","author":"Atienza-Mateo","year":"2019","journal-title":"Arthritis Rheuma"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib158","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon alpha in Behcet disease: review of the literature","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib159","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","article-title":"Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis","volume":"87","author":"Kotter","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib161","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00417-006-0346-y","article-title":"Results of interferon-alfa therapy in patients with Behcet uveitis","volume":"244","author":"Tugal-Tutkun","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib162","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/art.27581","article-title":"Long-term remission after cessation of interferon-alpha treatment in patients with severe uveitis due to Behcet's disease","volume":"62","author":"Deuter","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib163","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archophthalmol.2011.3","article-title":"Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behcet uveitis","volume":"129","author":"Onal","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib164","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/jop.2011.0238","article-title":"Results of interferon alpha-2a therapy in patients with Behcet's disease","volume":"28","author":"Yalcindag","year":"2012","journal-title":"J Ocul Pharm Ther"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/09273948.2016.1206204","article-title":"Long-term Efficacy of Interferon in Severe Uveitis Associated with Behcet Disease","volume":"25","author":"Diwo","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib166","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ajo.2008.08.038","article-title":"Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behcet disease","volume":"146","author":"Gueudry","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib167","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/09273948.2019.1606256","article-title":"Comparison of the Treatment Results for Behcet Uveitis in Patients Treated with Infliximab and Interferon","volume":"28","author":"Yalcindag","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib168","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","article-title":"Pegylation: a novel process for modifying pharmacokinetics","volume":"40","author":"Harris","year":"2001","journal-title":"Clin Pharm"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib169","first-page":"599","article-title":"Potential of Pegylated Interferon Alpha-2a in Behcet Uveitis: A Report of Five Cases","volume":"24","author":"Bielefeld","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09273948.2017.1332768","article-title":"Long-term efficacy of pegylated interferon Alpha-2b in Behcet's Uveitis: a small case series","volume":"27","author":"Celiker","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib171","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s10067-016-3527-z","article-title":"The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases","volume":"36","author":"Fabiani","year":"2017","journal-title":"Clin Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib172","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","article-title":"Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behcet's disease-related uveitis: a multicenter retrospective observational study","volume":"36","author":"Fabiani","year":"2017","journal-title":"Clin Rheuma"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib173","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/09273948.2017.1355471","article-title":"Tocilizumab for the treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy","volume":"26","author":"Eser Ozturk","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib174","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kex480","article-title":"Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behcet's disease: multicentre retrospective study","volume":"57","author":"Atienza-Mateo","year":"2018","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.55563\/clinexprheumatol\/9ipkcs","article-title":"Tocilizumab in Behcet's disease with refractory ocular and\/or neurological involvement: response according to different clinical phenotypes","volume":"39 132","author":"Atienza-Mateo","year":"2021","journal-title":"Clin Exp Rheuma"},{"key":"10.1016\/j.apjo.2025.100261_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152153","article-title":"Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients","volume":"58","author":"Barroso-Garcia","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib177","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00296-019-04259-y","article-title":"The right place of interleukin-1 inhibitors in the treatment of Behcet's syndrome: a systematic review","volume":"39","author":"Bettiol","year":"2019","journal-title":"Rheuma Int"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib178","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/a-1741-8104","article-title":"Janus Kinase Inhibitors: Next-Generation Treatment for Uveitis","volume":"239","author":"El-Shabrawi","year":"2022","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.apjo.2025.100261_bib179","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"Jaks and STATs: biological implications","volume":"16","author":"Leonard","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/gene.2014.80","article-title":"Activation of the JAK\/STAT pathway in Behcet's disease","volume":"16","author":"Tulunay","year":"2015","journal-title":"Genes Immun"},{"issue":"15","key":"10.1016\/j.apjo.2025.100261_bib181","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029189","article-title":"Extended-release tofacitinib for refractory Behcet disease: A case report","volume":"101","author":"Wang","year":"2022","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib182","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1007\/s10792-023-02808-w","article-title":"Optimizing glucocorticoid therapy for Behcet's uveitis: efficacy, adverse effects, and advances in combination approaches","volume":"43","author":"Li","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib183","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2352019","article-title":"Use of corticosteroids in non-infectious uveitis - expert consensus in Taiwan","volume":"56","author":"Chang","year":"2024","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib184","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/jop.2007.0015","article-title":"Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behcet disease","volume":"23","author":"Tuncer","year":"2007","journal-title":"J Ocul Pharm Ther"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jcjo.2014.03.004","article-title":"Long-term results of fluocinolone acetonide intravitreal implant in Behcet intractable posterior uveitis","volume":"49","author":"Oh","year":"2014","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib186","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000490674","article-title":"Efficacy of dexamethasone implants in uveitic macular Edema in cases with Behcet Disease","volume":"241","author":"Yalcinbayir","year":"2019","journal-title":"Ophthalmologica"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib187","first-page":"415","article-title":"Intravitreal dexamethasone implant as an adjunct weapon for severe and refractory uveitis in Behcet's disease","volume":"19","author":"Fabiani","year":"2017","journal-title":"Isr Med Assoc J Jul"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib188","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajo.2012.03.035","article-title":"Intravitreal infliximab for sight-threatening relapsing uveitis in Behcet disease: a pilot study in 15 patients","volume":"154","author":"Markomichelakis","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib189","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/IAE.0000000000001109","article-title":"Intravitreal infliximab in refractory uveitis in Behcet's disease: a safety and efficacy clinical study","volume":"36","author":"Hamza","year":"2016","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib190","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/IAE.0000000000003095","article-title":"MONTHLY INTRAVITREAL INFLIXIMAB IN BEHCET's DISEASE ACTIVE POSTERIOR UVEITIS: A Long-Term Safety Study","volume":"41","author":"Refaat","year":"2021","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib191","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ophtha.2009.12.011","article-title":"Intravitreal adalimumab for refractory uveitis-related macular edema","volume":"117","author":"Androudi","year":"2010","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib192","first-page":"319","article-title":"Intravitreal Adalimumab in Active Noninfectious Uveitis: A Pilot Study","volume":"24","author":"Hamam","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib193","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/09273948.2017.1335756","article-title":"Intravitreal Adalimumab for the Control of Breakthrough Intraocular Inflammation","volume":"26","author":"Kheir","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib194","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00296-004-0484-7","article-title":"A. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behcet's disease","volume":"25","author":"Erdem","year":"2005","journal-title":"Rheuma Int"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib195","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/112067210901900616","article-title":"Inflammatory mediators and posterior segment involvement in ocular Behcet disease","volume":"19","author":"Ozdamar","year":"2009","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib196","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/09273940802553295","article-title":"Intravitreal bevacizumab (Avastin) for the treatment of cystoid macular edema in Behcet disease","volume":"17","author":"Mirshahi","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib197","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.ophtha.2006.11.028","article-title":"Intravitreal bevacizumab for treatment of uveitic macular edema","volume":"114","author":"Cordero Coma","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib198","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/jovr.jovr_254_15","article-title":"Characteristics of Macular Edema in Behcet disease after intravitreal Bevacizumab injection","volume":"12","author":"Ghassemi","year":"2017","journal-title":"J Ophthalmic Vis Res"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib199","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5152\/eurjrheum.2020.20138","article-title":"Biologic treatments in Behcet's disease","volume":"8","author":"Alibaz-Oner","year":"2021","journal-title":"Eur J Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10067-016-3480-x","article-title":"Efficacy and safety of adalimumab in Behcet's disease-related uveitis: a multicenter retrospective observational study","volume":"36","author":"Fabiani","year":"2017","journal-title":"Clin Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2015.07.001","article-title":"The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management","volume":"61","author":"Foster","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10792-006-9006-9","article-title":"Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behcet's disease","volume":"26","author":"Abu El-Asrar","year":"2005","journal-title":"Int Ophthalmol"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib203","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ophtha.2018.02.020","article-title":"Successful optimization of adalimumab therapy in refractory Uveitis due to Behcet's disease","volume":"125","author":"Martin-Varillas","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100261_bib204","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2147\/TCRM.S232660","article-title":"Behcet's disease in children: diagnostic and management challenges","volume":"16","author":"Costagliola","year":"2020","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib205","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","article-title":"Demographic and clinical properties of juvenile-onset Behcet's disease: a controlled multicenter study","volume":"58","author":"Karincaoglu","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib206","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","article-title":"Clinical features of Behcet's disease in children: an international collaborative study of 86 cases","volume":"132","author":"Kone-Paut","year":"1998","journal-title":"J Pedia"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib207","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09273948.2011.555592","article-title":"Behcet disease in children","volume":"19","author":"Atmaca","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib208","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12969-017-0213-x","article-title":"A national cohort study on pediatric Behcet's disease: cross-sectional data from an Italian registry","volume":"15","author":"Gallizzi","year":"2017","journal-title":"Pedia Rheuma Online J"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib209","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/rheumatology\/38.5.457","article-title":"Childhood Behcet's disease: clinical features and comparison with adult-onset disease","volume":"38","author":"Krause","year":"1999","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib210","first-page":"48","article-title":"Comparing the clinical profile of adults and children with Behcet's syndrome in the UK","volume":"37 121","author":"Makmur","year":"2019","journal-title":"Clin Exp Rheuma"},{"issue":"6 115","key":"10.1016\/j.apjo.2025.100261_bib211","first-page":"135","article-title":"Paediatric Behcet's disease in Iran: report of 204 cases","volume":"36","author":"Shahram","year":"2018","journal-title":"Clin Exp Rheuma"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib212","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s10067-016-3187-z","article-title":"Paediatric Behcet's disease: a UK tertiary centre experience","volume":"35","author":"Nanthapisal","year":"2016","journal-title":"Clin Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib213","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12887-019-1613-5","article-title":"Clinical manifestations and anti-TNF alpha therapy of juvenile Behcet's disease in Taiwan","volume":"19","author":"Hu","year":"2019","journal-title":"BMC Pedia"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib214","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/14397595.2021.1891670","article-title":"Distinct clinical characteristics of pediatric Behcet's syndrome: A study from a referral center in China","volume":"31","author":"Zou","year":"2021","journal-title":"Mod Rheuma"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12969-016-0070-z","article-title":"Behcet's disease in children, an overview","volume":"14","author":"Kone-Paut","year":"2016","journal-title":"Pedia Rheuma Online J"},{"key":"10.1016\/j.apjo.2025.100261_bib216","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X241275822","article-title":"Uveitis in paediatric Behcet disease: a large multicentric Italian cohort","volume":"16","author":"Maccora","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib217","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0002-9394(03)00791-8","article-title":"Childhood-onset uveitis in Behcet disease:a descriptive study of 36 cases","volume":"136","author":"Tugal-Tutkun","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib218","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaapos.2009.04.016","article-title":"Ocular findings in childhood-onset Behcet disease","volume":"13","author":"Citirik","year":"2009","journal-title":"J AAPOS"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib219","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12886-023-03197-5","article-title":"Ocular involvement in pediatric Behcet's disease: is it different than in adults? (a short case series and mini review)","volume":"23","author":"Azri","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-022-02782-1","article-title":"Clinical heterogeneity of ocular Behcet's syndrome versus intestinal Behcet's syndrome: a cross-sectional study from Shanghai Behcet's syndrome database","volume":"24","author":"Hou","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib221","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12519-023-00785-9","article-title":"Clinical heterogeneity and five phenotypes identified in pediatric Behcet's syndrome: a cohort study from Shanghai Behcet's syndrome database","volume":"20","author":"Hu","year":"2024","journal-title":"World J Pedia"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib222","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s10067-019-04570-w","article-title":"Behcet's disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature","volume":"38","author":"Gheita","year":"2019","journal-title":"Clin Rheuma"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib223","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40259-023-00613-6","article-title":"Treatment with Biologic Drugs in Pediatric Behcet's Disease: A Comprehensive Analysis of the Published Data","volume":"37","author":"Batu","year":"2023","journal-title":"BioDrugs"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib224","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/kem199","article-title":"Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease","volume":"46","author":"Guillaume-Czitrom","year":"2007","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12969-019-0333-6","article-title":"Early administration of adalimumab for paediatric uveitis due to Behcet's disease","volume":"17","author":"Hiyama","year":"2019","journal-title":"Pedia Rheuma Online J"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib226","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12348-019-0181-z","article-title":"Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis","volume":"9","author":"Ho","year":"2019","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib227","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/rheumatology\/36.2.234","article-title":"Behcet's disease and pregnancy relationship study","volume":"36","author":"Marsal","year":"1997","journal-title":"Br J Rheuma"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib228","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1346-8138.2003.tb00423.x","article-title":"The clinical course of Behcet's disease in pregnancy: a retrospective analysis and review of the literature","volume":"30","author":"Uzun","year":"2003","journal-title":"J Dermatol"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib229","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/art.38052","article-title":"Behcet's disease and pregnancy","volume":"65","author":"Noel","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib230","first-page":"585","article-title":"Behcet's Disease and Pregnancy: A Retrospective Case-control Study","volume":"94","author":"Barros","year":"2021","journal-title":"Yale J Biol Med"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib231","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1515\/jpm-2018-0161","article-title":"Behcet's disease and pregnancy: obstetrical and neonatal outcomes in a population-based cohort of 12 million births","volume":"47","author":"Lee","year":"2019","journal-title":"J Perinat Med"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib232","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1346-8138.1998.tb02446.x","article-title":"The levels of plasma interleukin-2 and soluble interleukin-2R in Behcet's disease: a marker of disease activity","volume":"25","author":"Alpsoy","year":"1998","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib233","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1346-8138.1994.tb01762.x","article-title":"Interleukin 8 in Behcet's disease","volume":"21","author":"Itoh","year":"1994","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib234","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1258\/om.2009.090033","article-title":"Behcet's syndrome in pregnancy","volume":"3","author":"Martineau","year":"2010","journal-title":"Obstet Med"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib235","first-page":"183","article-title":"Behcet's syndrome in pregnancy and after the delivery","volume":"14","author":"Larsson","year":"1987","journal-title":"J Rheuma"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib236","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.0001-6349.2005.00761.x","article-title":"Behcet's disease and pregnancy","volume":"84","author":"Jadaon","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib237","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00005792-197505000-00001","article-title":"Behcet's disease. Report of 41 cases and a review of the literature","volume":"54","author":"Chajek","year":"1975","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib238","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W","article-title":"Population-based case-control study of teratogenic potential of corticosteroids","volume":"56","author":"Czeizel","year":"1997","journal-title":"Teratology"},{"issue":"915","key":"10.1016\/j.apjo.2025.100261_bib239","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/pmj.78.915.23","article-title":"Inflammatory bowel disease in pregnancy","volume":"78","author":"Alstead","year":"2002","journal-title":"Post Med J"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib240","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/tera.10043","article-title":"Teratogen update: azathioprine and 6-mercaptopurine","volume":"65","author":"Polifka","year":"2002","journal-title":"Teratology"},{"issue":"8","key":"10.1016\/j.apjo.2025.100261_bib241","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar Oz","year":"2001","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib242","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/00007890-200012270-00010","article-title":"Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus","volume":"70","author":"Kainz","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib243","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9926(199802)57:2<51::AID-TERA2>3.0.CO;2-9","article-title":"Adult and two children with fetal methotrexate syndrome","volume":"57","author":"Bawle","year":"1998","journal-title":"Teratology"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib244","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib245","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jaci.2021.07.005","article-title":"Safety of anti-TNF agents in pregnancy","volume":"148","author":"De Felice","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib246","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12884-024-06443-w","article-title":"Anti-tumor necrosis factor-alpha therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib247","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.1.2.6","article-title":"Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding","volume":"1","author":"Raja","year":"2012","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib248","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/BOR.0000000000000044","article-title":"Contraception and pregnancy counselling in rheumatoid arthritis","volume":"26","author":"Ostensen","year":"2014","journal-title":"Curr Opin Rheuma"},{"key":"10.1016\/j.apjo.2025.100261_bib249","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2022.18","article-title":"TNF-alpha\/anti-TNF-alpha drugs and its effect on pregnancy outcomes","volume":"24","author":"Dai","year":"2022","journal-title":"Expert Rev Mol Med"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib250","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib251","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib252","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib253","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"Ruegg","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"6 102","key":"10.1016\/j.apjo.2025.100261_bib254","first-page":"82","article-title":"The association between the parenchymal neurological involvement and posterior uveitis in Behcet's syndrome","volume":"34","author":"Bitik","year":"2016","journal-title":"Clin Exp Rheuma"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib255","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/14397595.2018.1457424","article-title":"The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behcet's disease","volume":"29","author":"Suwa","year":"2019","journal-title":"Mod Rheuma"},{"key":"10.1016\/j.apjo.2025.100261_bib256","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9518065","article-title":"Vision-Threatening Behcet's disease: severity of ocular involvement predictors","volume":"2018","author":"Hussein","year":"2018","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100261_bib257","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.720694","article-title":"Machine learning techniques for personalised medicine approaches in immune-mediated chronic inflammatory diseases: applications and challenges","volume":"12","author":"Peng","year":"2021","journal-title":"Front Pharm"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib258","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","article-title":"Vascular involvement in Behcet's syndrome: a retrospective analysis of associations and the time course","volume":"53","author":"Tascilar","year":"2014","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib259","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","article-title":"Neuro-Behcet's disease: epidemiology, clinical characteristics, and management","volume":"8","author":"Al-Araji","year":"2009","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib260","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/s10165-011-0533-5","article-title":"Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis","volume":"22","author":"Hirohata","year":"2012","journal-title":"Mod Rheuma"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib261","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/art.38351","article-title":"Long-term outcome of neuro-Behcet's disease","volume":"66","author":"Noel","year":"2014","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.apjo.2025.100261_bib262","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2016.12.001","article-title":"An elevated pro-inflammatory cytokines profile in Behcet's disease: A multiplex analysis","volume":"186","author":"Gholijani","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.apjo.2025.100261_bib263","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.699903","article-title":"Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behcet's Uveitis: A Randomized Controlled Prospective Study","volume":"12","author":"Qian","year":"2021","journal-title":"Front Pharm"},{"issue":"4 84","key":"10.1016\/j.apjo.2025.100261_bib264","first-page":"S149","article-title":"Anti-cytokine biologic treatment beyond anti-TNF in Behcet's disease","volume":"32","author":"Arida","year":"2014","journal-title":"Clin Exp Rheuma"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib265","first-page":"2040","article-title":"Infliximab for parenchymal neuro-Behcet's syndrome: case series and meta-analysis","volume":"42","author":"Wang","year":"2024","journal-title":"Clin Exp Rheuma"},{"key":"10.1016\/j.apjo.2025.100261_bib266","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2018.09.002","article-title":"Efficacy of the anti-IL 17 secukinumab in refractory Behcet's syndrome: a preliminary study","volume":"97","author":"Di Scala","year":"2019","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib267","doi-asserted-by":"crossref","first-page":"380","DOI":"10.14744\/SEMB.2023.89083","article-title":"Vascular Involvement in Behcet's Disease: an Evaluation of 147 Cases and Literature Review","volume":"57","author":"Atalar","year":"2023","journal-title":"Sisli Etfal Hast Tip Bul"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib268","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0003319715586290","article-title":"Neutrophil-Lymphocyte Ratio in Behcet Disease","volume":"66","author":"Ozturk","year":"2015","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib269","doi-asserted-by":"crossref","first-page":"258","DOI":"10.46497\/ArchRheumatol.2021.8423","article-title":"Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Behcet's disease with symptoms or signs of vascular involvement: a cross-sectional study","volume":"36","author":"Kaymaz","year":"2021","journal-title":"Arch Rheuma"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib270","doi-asserted-by":"crossref","first-page":"iii101","DOI":"10.1093\/rheumatology\/kez626","article-title":"Behcet: the syndrome","volume":"59","author":"Bettiol","year":"2020","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib271","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.27568","article-title":"Mortality in Behcet's disease","volume":"62","author":"Saadoun","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3 72","key":"10.1016\/j.apjo.2025.100261_bib272","first-page":"S80","article-title":"Behcet's syndrome: a critical digest of the recent literature","volume":"30","author":"Hatemi","year":"2012","journal-title":"Clin Exp Rheuma"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib273","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112318","article-title":"Old and New Challenges in Uveitis Associated with Behcet's Disease","volume":"10","author":"Gueudry","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib274","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00061198-200412000-00002","article-title":"Incidence of secondary glaucoma in behcet disease","volume":"13","author":"Elgin","year":"2004","journal-title":"J Glaucoma"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib275","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/eye.2008.56","article-title":"Ocular Behcet's disease presenting with retinal tear and panuveitis","volume":"22","author":"Ornek","year":"2008","journal-title":"Eye"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib276","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjaa468","article-title":"Successful repair of combined tractional and rhegmatogenous retinal detachment with pars plana vitrectomy without scleral buckle in severe Behcet's disease","volume":"2020","author":"Gasparian","year":"2020","journal-title":"J Surg Case Rep"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib277","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0886-3350(01)01023-9","article-title":"Cataract surgery in patients with Behcet's disease","volume":"28","author":"Kadayifcilar","year":"2002","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib278","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s40123-024-00991-2","article-title":"Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uveitic Glaucoma","volume":"13","author":"Xia","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib279","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/eye.2010.174","article-title":"The UK National Cyclodiode Laser Survey","volume":"25","author":"Agrawal","year":"2011","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib280","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1022587012611","article-title":"Pars plana vitrectomy in ocular Behcet's disease","volume":"24","author":"Soylu","year":"2001","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib281","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/ICU.0b013e32834bbe91","article-title":"Ocular Behcet disease: current therapeutic approaches","volume":"22","author":"Evereklioglu","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"10.1016\/j.apjo.2025.100261_bib282","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Behcet disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.apjo.2025.100261_bib283","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.ophtha.2004.04.026","article-title":"A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation","volume":"111","author":"Paganelli","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib284","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib285","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10384-010-0824-y","article-title":"Intraocular surgery in patients receiving infliximab therapy for Behcet disease","volume":"54","author":"Sakai","year":"2010","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib286","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000329091","article-title":"Cataract Surgery in Behcet's Disease Patients One Week after Infliximab Administration","volume":"2","author":"Handa","year":"2011","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib287","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcrs.2006.10.038","article-title":"Phacoemulsification cataract extraction and intraocular lens implantation in patients with uveitis","volume":"33","author":"Kawaguchi","year":"2007","journal-title":"J Cataract Refract Surg"},{"issue":"7","key":"10.1016\/j.apjo.2025.100261_bib288","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcrs.2013.02.053","article-title":"Phacoemulsification with intraocular lens implantation in patients with anterior uveitis","volume":"39","author":"Kosker","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.apjo.2025.100261_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2024.100082","article-title":"Managing a patient with uveitis in the era of artificial intelligence: Current approaches, emerging trends, and future perspectives","volume":"13","author":"Rojas-Carabali","year":"2024","journal-title":"Asia Pac J Ophthalmol"},{"issue":"2","key":"10.1016\/j.apjo.2025.100261_bib290","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.apjo.2025.100261_bib291","unstructured":"Dean L. Azathioprine Therapy and TPMT and NUDT15 Genotype. In: Pratt V.M., Scott S.A., Pirmohamed M., Esquivel B., Kattman B.L., Malheiro A.J., eds. Medical Genetics Summaries. 2012."},{"key":"10.1016\/j.apjo.2025.100261_bib292","series-title":"Table of pharmacogenomic biomarkers in drug labeling","author":"FDA","year":"2023"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib293","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2217\/pgs-2015-0004","article-title":"The potential of genetically guided treatment in Behcet's disease","volume":"17","author":"Gheita","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.apjo.2025.100261_bib294","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/08820139.2019.1698600","article-title":"Association of Interleukin-23R Gene Polymorphisms with Behcet's Disease Susceptibility: A Meta-Analysis of Case-control Studies","volume":"49","author":"Gong","year":"2020","journal-title":"Immunol Invest"},{"key":"10.1016\/j.apjo.2025.100261_bib295","article-title":"Causal role of immune cells in uveitis: Mendelian randomization study","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.apjo.2025.100261_bib296","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/gim.2017.21","article-title":"Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research","volume":"19","author":"Phillips","year":"2017","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib297","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","article-title":"Intraocular cytokine environment in active Behcet uveitis","volume":"142","author":"Ahn","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.apjo.2025.100261_bib298","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ophtha.2014.12.033","article-title":"Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy","volume":"122","author":"Letko","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.apjo.2025.100261_bib299","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-024-03123-6","article-title":"Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances","volume":"21","author":"Guan","year":"2024","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.apjo.2025.100261_bib300","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2024.100090","article-title":"Latest developments of generative artificial intelligence and applications in ophthalmology","volume":"13","author":"Feng","year":"2024","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100261_bib301","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/APO.0000000000000582","article-title":"Developments in artificial intelligence for ophthalmology: federated learning","volume":"11","author":"Teo","year":"2022","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100261_bib302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2024.04.009","article-title":"Generative artificial intelligence in ophthalmology","volume":"70","author":"Waisberg","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100261_bib303","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/ICU.0000000000001111","article-title":"Artificial intelligence in ophthalmology","volume":"36","author":"Khossravi","year":"2025","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib304","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.survophthal.2023.02.007","article-title":"Artificial intelligence in uveitis: a comprehensive review","volume":"68","author":"Nakayama","year":"2023","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.apjo.2025.100261_bib305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.11.4.7","article-title":"Assessment of anterior uveitis through anterior-segment optical coherence tomography and artificial intelligence-based image analyses","volume":"11","author":"Sorkhabi","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.apjo.2025.100261_bib306","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/09273948.2022.2054433","article-title":"Artificial intelligence and imaging processing in optical coherence tomography and digital images in uveitis","volume":"30","author":"Abellanas","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.apjo.2025.100261_bib307","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13643-024-02682-2","article-title":"Leveraging artificial intelligence to enhance systematic reviews in health research: advanced tools and challenges","volume":"13","author":"Ge","year":"2024","journal-title":"Syst Rev"},{"issue":"9","key":"10.1016\/j.apjo.2025.100261_bib308","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092525","article-title":"A Comprehensive update on retinal vasculitis: etiologies, manifestations and treatments","volume":"11","author":"Agarwal","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.apjo.2025.100261_bib309","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","article-title":"Efficacy of anti-TNF alpha in severe and\/or refractory Behcet's disease: Multicenter study of 124 patients","volume":"62","author":"Vallet","year":"2015","journal-title":"J Autoimmun"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162098925001288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162098925001288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:51:30Z","timestamp":1773849090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162098925001288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":309,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2162098925001288"],"URL":"https:\/\/doi.org\/10.1016\/j.apjo.2025.100261","relation":{},"ISSN":["2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International consensuses and guidelines on managing ocular Beh\u00e7et\u2019s disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-Retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII) and the Academia Retina Internationalis (ARI)","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjo.2025.100261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Asia-Pacific Academy of Ophthalmology and Academy of Asia-Pacific Professors of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100261"}}